JUN 23, 2020 6:03 AM PDT

Nanosponges Mop up Viruses to Treat COVID Infections

WRITTEN BY: Tara Fernandez

 

Scientists have developed an experimental therapy for COVID-19 that uses coated nanoparticles to intercept SARS-CoV-2 infection. A collaborative effort between researchers at the University of California San Diego and Boston University have recently released promising data in the journal Nano Letters — the first step in the sprint to bring the therapy to COVID-19 patients.

The core of the innovation consists of tiny particles that are enveloped in a coating of human lung and immune cell membranes. The team named their innovation “nanosponges” after their ability to bind to and remove viral pathogens, much like the cleaning action of a sponge. Nanosponges act as molecular decoys, hindering the ability of the SARS-CoV-2 virus to infect lung cells by up to 90 percent in lab-based assays.

Liangfang Zhang, a nanoengineering professor at the UC San Diego and corresponding author of the study, explains the rationale behind nanosponges: "Traditionally, drug developers for infectious diseases dive deep on the details of the pathogen in order to find druggable targets. Our approach is different. We only need to know what the target cells are. And then we aim to protect the targets by creating biomimetic decoys."

 

 

A closer look at the structure of nanosponges reveals a biodegradable polymer core, surrounded in a shell made up of membrane extracts from lung epithelial cells and macrophages. These membranes decorate the surface of the nanoparticles with the same receptors that SARS-CoV-2 uses to gain entry into human cells during infection. Once administered to COVID-19 patients, trillions of these minuscule particles flood the lungs, latch on to the virus rendering them inactive, and are subsequently cleared by the body’s immune cells.

Nanosponges have an edge over many COVID-19 treatments that specifically target SARS-CoV-2 as they can be used to treat a wide spectrum of viruses that infect the respiratory tract and are can continue to be effective even if SARS-CoV-2 mutates. On top of that, they can also be designed to mop up inflammatory cytokine proteins that are responsible for potentially lethal COVID-19 “cytokine storms”. 

Zhang and colleagues are racing to bring nanosponge technology to the clinic, saying, "For COVID-19, I hope other teams come up with safe and effective therapies and vaccines as soon as possible. At the same time, we are working and planning as if the world is counting on us."

 

Sources: Technology Networks, Nano Letters


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
APR 15, 2020
Immunology
Why More Men than Women Die from COVID-19
APR 15, 2020
Why More Men than Women Die from COVID-19
As of April 9th, over 60% of deaths from COVID-19 in New York state were men. Meanwhile, as of April 6, 82% of patients ...
MAY 12, 2020
Immunology
Disabling Genes in Immune Cells Prevents Obesity
MAY 12, 2020
Disabling Genes in Immune Cells Prevents Obesity
Obesity is a $1.7 trillion problem in the United States — a value almost 10% of the nation’s gross domestic ...
MAY 08, 2020
Immunology
Vaccine Prevents Virally-induced Type 1 Diabetes
MAY 08, 2020
Vaccine Prevents Virally-induced Type 1 Diabetes
Scientists aren’t exactly sure what causes type 1 diabetes, although genetics and environmental factors are presum ...
JUN 04, 2020
Immunology
Tissue Stiffness Regulates Immune Responses
JUN 04, 2020
Tissue Stiffness Regulates Immune Responses
  Cells are remarkably sensitive to the mechanical properties of their environment, changing their behavior as a re ...
JUL 17, 2020
Immunology
More Potential Antibody Therapies for COVID Emerge
JUL 17, 2020
More Potential Antibody Therapies for COVID Emerge
When it comes to clinical countermeasures against COVID-19, one class of molecules stands out among the others: antibodi ...
AUG 11, 2020
Drug Discovery & Development
Scientists Discover Key Gene Behind Antibiotic Resistance
AUG 11, 2020
Scientists Discover Key Gene Behind Antibiotic Resistance
Scientists from Oxford University have shown that a single gene can make some strains of Staphylococcus aureus (the bact ...
Loading Comments...